Induction of gastric histamine synthesis by H2-receptor antagonists: Potentiation of their antisecretory activity by histidine decarboxylase inhibitors
- 1 September 1980
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 10 (4) , 302-308
- https://doi.org/10.1007/bf01971429
Abstract
The activation of histamine (HA) formation in rat stomach was measured after repeated administrations of histamine H2-receptor antagonists and the potentiation of their antisecretory activity was examined in histidine decarboxylase inhibitor (HDI)-pretreated rats. 40 mg/kg of metiamide, given intraperitoneally (i.p.) 24, 16 and 2 h prior to the examination, produced approximately 50% increase in the amount of14C-histamine, formed from14C-histidine in the stomach, and an almost equal enhancement in the gastric histidine decarboxylase (HD) activity. An equal dose of the compound did not influence the endogenous histamine level in the glandular stomach whereas it caused a significant increase in the serum histamine content. By similar treatment, 10 mg/kg of cimetidine enhanced the newly formed histamine in the rat stomach by 57%. The potent HDI, 2-hydroxy-5-carbomethoxy-benzyloxyamine (GYKI-11 121) suppressed the metiamide- and eimetidine-induced increases in histamine synthesis to slightly above or below the control values. In pharmacological studies, the antisecretory activity of histamine H2-receptor blockers could markedly be potentiated by HDI. In GYKI-11 121 and NSD-1055-pretreated rats, the inhibiting potency of metiamide and cimetidine on pentagastrin-stimulated gastric acid secretion, increased to approximately twice that of the original effect. Neither GYKI-11 121 nor NSD-1055 produced significant inhibition on pentagastrin-stimulated gastric acid secretion in the applied doses. These findings provided evidence for the feedback stimulation of gastric HA synthesis by H2-receptor blockers and confirmed the role of HA in the gastric acid secretion. Potentiation of the antisecretory activity of H2-receptor antagonists by HDI would be useful in the therapeutic application of these compounds.This publication has 25 references indexed in Scilit:
- H1+H2-receptor antagonists for premedication in anaesthesia and surgery: A critical view based on randomized clinical trials with haemaccel and various antiallergic drugsInflammation Research, 1980
- Regulation of histamine synthesis: Metiamide-induced synthesis of histamine in the rat stomach and the effect of histidine decarboxylase inhibitors on the elevated14C-histamine level and histidine decarboxylase activityInflammation Research, 1978
- Non-mast cell histamine levels in rat tissues after histidine loadingEuropean Journal of Pharmacology, 1977
- Metiamide — An orally active histamine H2-receptor antagonistInflammation Research, 1973
- 2-Hydroxy-5-carbomethoxybenzyloxyamine: A new potent inhibitor of histidine decarboxylaseBiochemical Pharmacology, 1973
- ISOTOPIC MICROASSAY OF HISTAMINE, HISTIDINE, HISTIDINE DECARBOXYLASE AND HISTAMINE METHYLTRANSFERASE IN BRAIN TISSUE1Journal of Neurochemistry, 1972
- Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- Die Wirkung des Histidindecarboxylase-Hemmstoffs Brocresine (NSD-1055) auf die Magenhistidindecarboxylase und die SalzsÄuresekretion von RattenNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1970
- Histamine Synthesis and Gastric Secretion after Portacaval ShuntScience, 1965
- Inhibition of histamine synthesis in the rat by α-hydrazino analog of histidine and 4-bromo-3-hydroxy benzyloxyamineBiochemical Pharmacology, 1965